Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathryn Daveson

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Infection, Disease & Health|October 16, 2019
Two carbapenemase-producing Enterobacteriaceae outbreaks detected retrospectively by whole-genome sequencing at an Australian tertiary hospitalAlexandra Marmor, Kathryn Daveson, David Harley, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|August 30, 2018
Chlorhexidine washing in intensive care does not reduce bloodstream infections, blood culture contamination and drug-resistant microorganism acquisition: an interrupted time series analysisRoel Kengen, Elcke Thoonen, Kathryn Daveson, et al.
Infection Control and Hospital Epidemiology|March 15, 2019
Vancomycin-resistant Enterococcus (VRE) outbreak in a neonatal intensive care unit and special care nursery at a tertiary-care hospital in Australia-A retrospective case-control studyPatiyan Andersson, Wendy Beckingham, Claire Louise Gorrie, et al.
Internal Medicine Journal|December 22, 2021
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic stem cell transplant recipients, 2021Maggie M Chau, Kathryn Daveson, Jan-Willem C Alffenaar, et al.
International Journal of Antimicrobial Agents|September 28, 2020
Therapeutic drug monitoring of commonly used anti-infective agents: A nationwide cross-sectional survey of Australian hospital practicesSahand Imani, Jan-Willem Alffenaar, Menino O Cotta, et al.
Peerj|August 9, 2020
Antimicrobial stewardship in remote primary healthcare across northern AustraliaWill Cuningham, Lorraine Anderson, Asha C Bowen, et al.
British Journal of Clinical Pharmacology|July 21, 2021
Emerging therapeutic drug monitoring of anti-infective agents in Australian hospitals: Availability, performance and barriers to implementationIndy Sandaradura, Jan-Willem Alffenaar, Menino O Cotta, et al.
Mycoses|November 13, 2020
Risk factors for candidaemia: A prospective multi-centre case-control studyCaitlin Livia Keighley, Alun Pope, Deborah J E Marriott, et al.
International Journal of Antimicrobial Agents|August 27, 2016
Antifungal susceptibilities of non-Aspergillus filamentous fungi causing invasive infection in Australia: support for current antifungal guideline recommendationsCatriona L Halliday, Sharon C-A Chen, Sarah E Kidd, et al.
International Journal of Antimicrobial Agents|March 15, 2023
LInezolid Monitoring to MInimise Toxicity (LIMMIT1): A multicentre retrospective review of patients receiving linezolid therapy and the impact of therapeutic drug monitoringCindy Lau, Deborah Marriott, Jessica Bui, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Infection, Disease & Health|October 16, 2019
Two carbapenemase-producing Enterobacteriaceae outbreaks detected retrospectively by whole-genome sequencing at an Australian tertiary hospitalAlexandra Marmor, Kathryn Daveson, David Harley, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|August 30, 2018
Chlorhexidine washing in intensive care does not reduce bloodstream infections, blood culture contamination and drug-resistant microorganism acquisition: an interrupted time series analysisRoel Kengen, Elcke Thoonen, Kathryn Daveson, et al.
Infection Control and Hospital Epidemiology|March 15, 2019
Vancomycin-resistant Enterococcus (VRE) outbreak in a neonatal intensive care unit and special care nursery at a tertiary-care hospital in Australia-A retrospective case-control studyPatiyan Andersson, Wendy Beckingham, Claire Louise Gorrie, et al.
Internal Medicine Journal|December 22, 2021
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic stem cell transplant recipients, 2021Maggie M Chau, Kathryn Daveson, Jan-Willem C Alffenaar, et al.
International Journal of Antimicrobial Agents|September 28, 2020
Therapeutic drug monitoring of commonly used anti-infective agents: A nationwide cross-sectional survey of Australian hospital practicesSahand Imani, Jan-Willem Alffenaar, Menino O Cotta, et al.
Peerj|August 9, 2020
Antimicrobial stewardship in remote primary healthcare across northern AustraliaWill Cuningham, Lorraine Anderson, Asha C Bowen, et al.
British Journal of Clinical Pharmacology|July 21, 2021
Emerging therapeutic drug monitoring of anti-infective agents in Australian hospitals: Availability, performance and barriers to implementationIndy Sandaradura, Jan-Willem Alffenaar, Menino O Cotta, et al.
Mycoses|November 13, 2020
Risk factors for candidaemia: A prospective multi-centre case-control studyCaitlin Livia Keighley, Alun Pope, Deborah J E Marriott, et al.
International Journal of Antimicrobial Agents|August 27, 2016
Antifungal susceptibilities of non-Aspergillus filamentous fungi causing invasive infection in Australia: support for current antifungal guideline recommendationsCatriona L Halliday, Sharon C-A Chen, Sarah E Kidd, et al.
International Journal of Antimicrobial Agents|March 15, 2023
LInezolid Monitoring to MInimise Toxicity (LIMMIT1): A multicentre retrospective review of patients receiving linezolid therapy and the impact of therapeutic drug monitoringCindy Lau, Deborah Marriott, Jessica Bui, et al.
Pageof 1